Outcomes of Second Line Fludarabine Therapy

Parameter % of Patients

Response Rate 21-48%

Grade 4 thrombocytopenia ~ 27%

Grade 4 neutropenia 17-59%

Major Infections 16-58%

Died on Study 20-35%

Median Survival 9-12.6 months

CLL Overview

Previous slide

Next slide

Back to first slide

View graphic version